Biocompatibility and pharmacokinetic analysis of an intracameral polycaprolactone drug delivery implant for glaucoma

Kim J., Kudisch M., Mudumba S., Asada H., Aya-Shibuya E., Bhisitkul R.B., Desai T.A.

2016
Investigative Ophthalmology and Visual Science

Therapeutic Area

Glaucoma
Technology

Drug Delivery

Affiliations

San Francisco, CA, United States; Department of Ophthalmology, University of California, San Francisco, San Francisco, CA, United States; Santen, Inc., Emeryville, CA, United States; Santen Pharmaceutical Co., Ltd., Nara RD Center, Nara, Japan; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA, United States

Related Publications

Felodipine re-positioned as a neuroprotectant via improved optic nerve head blood circulation in retinal ischemic rabbits and ocular hypertensive rats

Taniguchi T, Akaishi T, Hata T, Yamashita R, Esaki Y, Morofuji R, Okabe K, Fuwa M, Yamamoto Y, Guo L, Choi S, Luong V, Ota T, Sharif NA, Cordeiro MF, Kageyama M.

A Study of 24-h Efficacy and Safety of Sepetaprost vs. Latanoprost in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension

Konstas A.G.; Garhöfer G.; Lübke Y.; Voykov B.; Ropo A.

Valproic Acid Application to Modify Post Surgical Fibrosis in a Model of Minimally Invasive Bleb Surgery

Lo P.F.; Gunawan M.; Yap Z.L.; Leong C.; Kwek F.; Varadarajan J.; Wang X.; Kageyama M.; Wong T.T.

View all Glaucoma publications